Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 34,306 | 28,433 | 23,286 | 18,821 | 17,868 |
| Cost of Goods | 13,062 | 12,441 | 10,946 | 9,630 | 7,289 |
| Gross Profit | 21,244 | 15,992 | 12,340 | 9,191 | 10,579 |
| Operating Expenses | 19,310 | 18,022 | 18,268 | 3,033 | 12,227 |
| Operating Income | 1,996 | -1,589 | -4,982 | 6,788 | -1,359 |
| Interest Expense | 1,097 | 712 | 661 | 716 | 674 |
| Other Income | 144 | 75 | 104 | 62 | 97 |
| Pre-tax Income | 1,043 | -2,226 | -5,539 | 6,134 | -1,936 |
| Net Income Continuous | 1,043 | -2,226 | -5,539 | 6,134 | -1,936 |
| Net Income | $1,043 | $-2,226 | $-5,539 | $6,134 | $-1,936 |
| EPS Basic Total Ops | 0.01 | -0.01 | -0.03 | 0.04 | -0.01 |
| EPS Basic Continuous Ops | 0.01 | -0.01 | -0.03 | 0.04 | -0.01 |
| EPS Diluted Total Ops | 0.01 | -0.01 | -0.03 | 0.04 | -0.01 |
| EPS Diluted Continuous Ops | 0.01 | -0.01 | -0.03 | 0.04 | -0.01 |
| EBITDA(a) | $2,574 | $-929 | $-4,304 | $7,704 | $-758 |